Cold Chain Expert Interviews
What will technologies will disrupt the life sciences supply chain industry in 2018? To find out, we sat down with Paul Zikopoulos, VP of Competitive and Big Data Analytics Teams and Future Trends Expert, IBM, and the 2017 Global Forum's keynote speaker.
By 2020, pharma cold chain logistics spend is predicted to exceed $16 billion. Despite this huge investment, Pharmaceutical supply chains still face tremendous challenges. We sat down with keynote speaker Jack Shaw, Executive Director of the American Blockchain Council, Technology Futurist to discuss this. Below is a preview of the interview:
What will be the Blockchain’s direct impact on the Pharmaceutical supply chain?
Pharmaceutical supply chains face tremendous challenges. Ingredients get lost, chemicals become inactive due to insufficient temperature control, medicines are wrongly prescribed by malfunctioning computer systems, and counterfeit medications slip through cracks in security.
All of these problems are causing pharma companies to turn to emerging technologies to improve visibility and control across the supply chain. Many companies have begun to realise the specific utility of blockchain technology in this endeavor.
The immutability of records, easy and transparent sharing of data among authorized ecosystem participants, and the virtually hack-proof
capabilities of Blockchain (also known as Distributed Ledger Technology, or DLT) make it a
powerful and effective choice for better managing supply chains of all kinds.
How will Blockchain technology affect cold chain logistics now and in the near future?
Blockchain offers an efficient way for wholesalers and dispensaries to optimize their inventory management and control, anticipate supply shortages, and improve data integrity as well as the distribution of data that has not previously existed.
Download the full report to get more insights on:
-Blockchain's direct impact on the Pharma Supply Chain
-Blockchain technology's affect on cold chain logistics
-Cold chain pharmaceuticals' preparation for the future of technology
We sat down with David Merrit, Executive Vice President of Public Affairs and Strategy, America's Health Insurance Plans to discuss Healthcare Reform. Below is a preview of the interview:
How will healthcare reform affect the pharmaceutical supply chain?
"It seems you can’t talk health care today without talking about politics. How health reform will affect the supply chain depends on who’s in charge. The Trump Administration has put a very bright spotlight on rising prescription drug costs - from the very beginning of the process with manufacturers setting prices to the very end with what consumers pay at the pharmacy. Their focus has been on reducing regulation, increasing competition, and reducing what patients pay."
How does the national healthcare reform law affect the future of the pharma supply chain?
"Every American deserves access to affordable coverage and high-quality care. Policymakers and politicians will certainly debate how we balance affordability with access."
Download the Report to read the full conversation with David and hear what he has to say on:
- Healthcare Reform's affect on the pharma supply chain
- The national healthcare reform law affect on the future of the pharma supply Chain
- His advise on healthcare reform to the presidential campaigns
We sat down with one of our keynote speakers Bill Mahorney, Chief, Enforcement Division, FMCSA, Department of Transportation. As one of the key players responsible for enforcing the ELD Mandate, Bill will be addressing how this new law will affect the supply chain, logging books, hours of service regulations and cross-industry collaboration. To give you a sneak peek as to what you can expect to hear about onsite, we sat down with Bill to discuss what the ELD Mandate is and how it impacts the supply chain.
Serialization is set to revolutionize how business is done in pharma. It is a complex technical project involving engineering systems at line, distribution operation levels and enterprise IT systems, at site and global levels.
Coming back to today’s reality, and despite the years given for implementation, observers will be aware that a vast portion of the manufacturing landscape is behind schedule and is now scrambling to meet international compliance deadlines.
Download this whitepaper to discover:
- Golden rules for serialization projects
- The organizational and technical challenges that creep into serialization projects
- The dangers of leaving implementation too late
- How serialization powers pharma's digital transformation
Ahead of the 16th Global Forum taking place September 24-28, 2018 in Philadelphia, PA, we sat down with keynote speaker Tom Bonkenburg, Director, European Operations, St. Onge Company to discuss:
- How robotics are impacting the the pharma supply chain sector specifically
- Common barriers to automation adoption and how to overcome them
- What life sciences supply chain leaders need to do today to prepare for a future of increased automation